Abstracts

Search by keyword or author name.

Showing 852 abstracts.

Brookie M. Best, Alice Stek, Edmund Capparelli, Jiajia Wang, David Shapiro, Courtney Fletcher, Elizabeth Smith, Nahida Chakhtoura, Mark Mirochnick for the IMPAACT P1026 Protocol Team. Pregnancy-associated decrease in tenofovir exposure counteracted by concomitant lopinavir/ritonavir. Presented at: IAS 2015.

Conference

IAS 2015

Study

P1026S
Stein Schalkwijk, Rob ter Heine, Angela Colbers, Alwin Huitema, Palolo Denti, Kelly Dooley, Edmund Capparelli, Brookie Best, Tim Cressey, Rick Greupink, Frans Russel, Mark Mirochnick, David Burger. Pregnancy: a barrier to dose reduction of efavirenz?. Presented at: CROI 2016.

Conference

CROI 2016

Study

P1026S
George M. Johnson, M.D., YouGan Wang, Andrew A. Wiznia, M.D., Paul Krogstad, M.D., Sophia S. Lee, M.S., Francesca Aweeka, Pharm.D., Sandra Hayashi, Pharm.D., Sharon Appelbaum Nachman, M.D. Preliminary Evaluation Of Pharmacodynamics In Stable Antiretroviral Experienced HIV-Infected Children Following Initiation Of HAART.
Tim Roy Cressey, B.Sc., Ph.D., Nirun Vanprapar, M.D., M.Sc., Edmund Capparelli, Pharm.D., Wasana Prasitsuebsai, M.D., Linda Aurpibul, M.D., Petronella Muresan, M.S., Achara Eksaengsri, B.Pharm., Elizabeth (Betsy) Smith, M.D., Kenneth McIntosh, M.D., Ram Yogev, M.D., Kulkanya Chokephaibulkit, M.D. Preliminary Pharmacokinetics and Safety of a Novel Pediatric Fixed-Dose Combination (FDC) of Zidovudine (ZDV), Lamivudine (3TC) and Nevirapine (NVP) versus the Liquid Formulations in HIV-Infected Thai Children. Presented at: 10th Int'l Workshop on Clinical Pharmacology of HIV Therapy.

Conference

10th Int'l Workshop on Clinical Pharmacology of HIV Therapy

Study

P1069
Sandra K. Burchett, M.D., M.S., Andrea Kovacs, M.D., Margaret Khoury, M.D., Florence H. Yong, M.S., Vincent J. Carey, Ph.D., Margo Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Bonnie Zimmer, B.S., Elizabeth Hawkins. Preliminary Toxicity and Tolerability Of 4-Drug Antiretroviral (ARV) Therapy With NRTIs, Nevirapine (NVP) and Ritonavir (RTN) In ARV-Experienced Children With Advanced HIV DIsease.
KK Venkatesh, M Farhad, T Fenton, D Moodley, S Naik, C Nakabiito, L Fairlie, B Makanani, F Saidi, T Chipato, J McIntyre, MG Fowler, BH Chi, JSA Stringer for the PROMISE 1077BF team. Preterm birth among women with ultrasound-based gestational dating in PROMISE 1077BF. Presented at: CROI 2019; 2019 Mar 05.

Conference

CROI 2019

Study

1077BF
Prevalence and characterization of HIV-associated nephropathy and other renal disorders in a cohort of perinatally HIV-1 infected children.
Ceejay L. Boyce, Marley D. Bishop, Sheila M. Styrchak, Kevin Knowles, Cindy Vavro, Rohan Hazra, Ellen Townley, Robert Nixon, Robert A. Smith, Geoffrey S. Gottlieb, Theodore D. Ruel, Andrew A. Wiznia, Lisa M. Frenkel, IMPAACT P1093 Team. Prevalence and dynamics of drug resistance during dolutegravir-containing treatment in a pediatric population living with HIV-1 (IMPAACT P1093). Presented at: IAS 2023.

Conference

IAS 2023

Study

P1093, P1093
Ceejay Boyce. Prevalence and dynamics of drug resistance during dolutegravir-containing treatment in a pediatric population living with HIV-1 (IMPAACT P1093). Presented at: IAS 2023; 2023 Jul 26.

Conference

IAS 2023
Prevalence of Chlamydia and Gonorrhea in HIV-infected Pregnant Women in the Americas.